Clinical Trials Browser

Phase 2 × Melanoma × Monatide (IMS 3015) × Clear all

NCT00651703 2010-11-15

Safety and Immunogenicity of CYT004-MelQbG10 Vaccine With and Without Adjuvant in Advanced Stage Melanoma Patients

Phase 2 Completed

Melanoma